Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viread for HIV prevention in HIV-negative men
NCT00131677Phase 2Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- Feb 2005
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Centers for Disease Control and Prevention. Started Feb 2005; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00131677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131677.